Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373706 · ClinicalTrials.gov registry record · NA
Testing Brief Personalized Feedback Integrating EMA Alcohol Cue Information
A NA study of Alcohol Drinking and Problem Drinking, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT05373706: Completed NA study of Alcohol Drinking and Problem Drinking, sponsored by University of Washington.
NCT05373706 is a NA study of Alcohol Drinking and Problem Drinking that has completed, run by University of Washington. The registered enrollment target is 99 participants, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05373706, a NA study of Alcohol Drinking and Problem Drinking, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop a brief intervention that incorporates ecological momentary assessments (EMAs; i.e., four brief surveys per day for 17 days) to create personalized feedback targeting high-risk alcohol use among young adult drinkers. The intervention mainly focuses on providing feedback on individuals' drinking desire and how it varies as a function of a number of real-world factors. Other psycho-educational alcohol-related content is also provided in the intervention including strategies for decreasing exposure to cues that increase drinking desires and how to cope with increased desire to drink. This brief intervention will be used in a randomized controlled trial (RCT) comparing young adults who receive the intervention with those who only complete identical assessments.
Primary Outcome
Number of standard drinks consumed on each day of a typical week during the \[past 3 months for baseline and 3-month follow-up; past two weeks for 2-week follow-up\]. Participants responded on a scale from 0 (0 drinks) to 25 (25 or more drinks). Totals for each day are summed to calculate the typical number of drinks consumed per week.
Conditions Studied
Interventions
- BEHAVIORAL Alcohol Cue Reactivity Personalized Feedback Intervention
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2022-04-29 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT05373706 record still lists
NCT05373706 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 629-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Alcohol Cue Reactivity Personalized Feedback Intervention is the first listed.
NCT05373706 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05373706 about?
NCT05373706 is a clinical study titled "Testing Brief Personalized Feedback Integrating EMA Alcohol Cue Information". This study aims to develop a brief intervention that incorporates ecological momentary assessments (EMAs; i.e., four brief surveys per day for 17 days) to create personalized feedback targeting high-risk alcohol use among young adult drinkers. The intervention mainly focuses on providing feedback on...
What is the current status of trial NCT05373706?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2022-04-29. Estimated completion is 2023-05-01.
What conditions does trial NCT05373706 study?
This clinical trial studies the following conditions: Alcohol Drinking, Problem Drinking.
What interventions are being tested in trial NCT05373706?
The interventions under investigation include: Alcohol Cue Reactivity Personalized Feedback Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05373706?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05373706 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05373706's enrollment target sits among peer trials
99 59th of 85 higher than 27 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI